… a notable decline in Left Ventricular Ejection Fraction (LVEF). … antibody that interferes with
ErB2 (HER2/neu) signaling. It has … patients with breast cancer who had received anthracycline …

… in LV longitudinal systolic strain decrease anthracycline … with adjuvant chemotherapy, who
do not have a history of cardiac … Left ventricular systolic function in HER2/neu negative breast …

… early after anthracycline chemotherapy, and to identify … , defined as a reduction in left ventricular
ejection fraction (LVEF), … More recently, 2D myocardial strain imaging has been shown to …

… reliable than ejection fraction in follow-up of left ventricular function by … with either
anthracyclines alone or in combination with other … chemotherapy agents represented in this …

… chemotherapy regimens suggested an earlier recovery for … failure have suggested that left
ventricular systolic function did not … of anthracyclines and trastuzumab induced left ventricular …

… an anthracycline chemotherapeutic that causes myocardial and … antibody that disrupts ErbB2
(HER2/neu) signaling, a pathway … Changes in left ventricular ejection fraction by treatment …

… strain, almost replaced left ventricular ejection fraction as “the … of left ventricular systolic
function in large centers that treat a … of anthracycline chemotherapy in breast cancer patient (17). …

… LV ejection fraction (LVEF) and 36 segmental strain measures … after the completion of
anthracycline chemotherapy and this … Left ventricular systolic function in HER2/neu negative …

… % and a left ventricular ejection fraction (LVEF) of 66%. After 3 months of chemotherapy, there
… ECV was elevated in cancer patients treated with anthracycline and in those with reduced …

… to be very effective in treating patients with breast cancer over-… method employed to monitor
left ventricular (LV) function in … LV ejection fraction was obtained from the apical four- and two…